Works matching IS 0008543X AND DT 2005 AND VI 103 AND IP 8

Results: 33
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Author reply.

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1760
    By:
    • Simone Cesaro;
    • Ruggiero D'Elia
    Publication type:
    Article
    12

    Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphomaThe development of the model and the subsequent analyses were supported by a grant from Genentech, Inc. The sponsors of the study had no role in the model design, cost-utility analysis, or interpretation of the results. All investigators had unlimited access to the model and data. No limitations on publication were imposed. The authors made the final decisions on all analyses presented in the article.

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1644
    By:
    • John C. Hornberger;
    • Jennie H. Best
    Publication type:
    Article
    13
    14
    15
    16
    17

    Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinomaThe current study used the linked Surveillance, Epidemiology and End Results (SEER)-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, National Cancer Institute (Bethesda, MD); the Office of Research, Development and Information, Centers for Medicare and Medicaid Services (CMS; Baltimore, MD); Information Management Services, Inc. (Silver Springs, MD); and the SEER program tumor registries in the creation of the SEER-Medicare database.

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1615
    By:
    • Vahakn B. Shahinian;
    • Yong-fang Kuo;
    • Jean L. Freeman;
    • Eduardo Orihuela;
    • James S. Goodwin
    Publication type:
    Article
    18
    19

    Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2The following institutions participated in this study: CALGB Statistical Center, Durham, NC (Stephen George, Ph.D.; supported by grant CA336) Christiana Care Health Services, Inc. Community Cooperative Oncology Program (CCOP), Wilmington, DE (Stephen Grubbs, M.D; supported by grant CA45418); Dartmouth Medical SchoolNorris Cotton Cancer Center, Lebanon, NH (Marc S. Ernstoff, M.D.; supported by grant CA04326); Duke University Medical Center, Durham, NC (Jeffrey Crawford, M.D.; supported by grant CA47577); Greenville CCOP, Greenville, SC (Jeffrey Giguere, M.D.); Long Island Jewish Medical Center, Lake Success, NY (Marc Citron, M.D.; supported by grant CA11028); Rhode Island Hospital, Providence, RI (William Sikov, M.D.; supported by grant CA08025); Southeast Cancer Control Consortium Inc. CCOP, Goldsboro, NC (James N. Atkins, M.D.; supported by grant CA45808); State University of New York Upstate Me

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1670
    By:
    • Gerald Clamon;
    • James Herndon;
    • Jeffrey Kern;
    • Ramaswamy Govindan;
    • Jennifer Garst;
    • Dorothy Watson;
    • Mark Green
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemiaThe opinions or assertions contained herein are the private views of the authors and are not to be construed as reflecting the opinions of the Department of the Army or the Department of Defense.

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1725
    By:
    • Jacques Baillargeon;
    • Anne-Marie Langevin;
    • Margaret Lewis;
    • James J. Grady;
    • Paul J. Thomas;
    • Judith Mullins;
    • Jaime Estrada;
    • Aaron Pitney;
    • Nancy Sacks;
    • Brad H. Pollock
    Publication type:
    Article
    26
    27

    Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinomaThe authors dedicate this study to the memory of Dr. Iris Goldberg, a close friend and a collaborator for many years.Presented at the 10th International Congress of the Metastasis Research Society, Genoa, Italy, September 1720, 2004.

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1631
    By:
    • Sivan Elloul;
    • Mari Bukholt Elstrand;
    • Jahn M. Nesland;
    • Claes G. Trop;
    • Gunnar Kvalheim;
    • Iris Goldberg;
    • Reuven Reich;
    • Ben Davidson
    Publication type:
    Article
    28
    29

    Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistryPresented in part at the 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 30 through June 3, 2003.

    Published in:
    Cancer (0008543X), 2005, v. 103, n. 8, p. 1581
    By:
    • Anees Chagpar;
    • Lavinia P. Middleton;
    • Aysegul A. Sahin;
    • Funda Meric-Bernstam;
    • Henry M. Kuerer;
    • Barry W. Feig;
    • Merrick I. Ross;
    • Frederick C. Ames;
    • S. Eva Singletary;
    • Thomas A. Buchholz;
    • Vincente Valero;
    • Kelly K. Hunt
    Publication type:
    Article
    30
    31
    32
    33